Solifenacin: Clinical Trials

6 trials of Solifenacin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 2 unknown. 6 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 2, Recruiting 2, Unknown 2
Phase 12Unknown 2

Follow Solifenacin: new trials by email Literature Review of Solifenacin trials Research Report on Solifenacin

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Melatonin and Solifenacin for Double-J Ureteral Stent Symptoms
Solifenacin, Melatonin - Ureteral Stent-Related Symptoms, Ureteral Calculi
Phase 2RecruitingBeni-Suef University1892026-05-072026-06-02
A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type
Donepezil, Solifenacin - Dementia of Alzheimer's Type
Phase 2CompletedChase Pharmaceuticals Corporation, an affiliate of Allergan plc282015-10-072019-03-05
Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa
TOT, solifenacin - Surgical Treatment of Urge Incontinence
Phase 1 / Phase 2UnknownKlinikum der Universität Köln1202013-01-012015-04-07
Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women
solifenacin, cesa/vasa - Urge Urinary Incontinence
Phase 1 / Phase 2UnknownKlinikum der Universität Köln1202013-01-012015-04-07
Bacterial Genomic Sequencing in Overactive Bladder
Solifenacin - Overactive Bladder
Phase 2CompletedLoyola University1342012-07-012015-12-07
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
solifenacin, Clonidine - Hot Flashes, Breast Cancer
Phase 2RecruitingUniversity of Arkansas1102012-02-012026-03-05

Conditions studied

Urinary Incontinence, Urge (2)  ·  Breast Neoplasms (1)  ·  Hot Flashes (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Ureteral Calculi (1)  ·  Urinary Bladder, Overactive (1)  ·  Urinary Tract Infections (1)

Sponsors

Klinikum der Universität Köln (2)  ·  Beni-Suef University (1)  ·  Chase Pharmaceuticals Corporation, an affiliate of Allergan plc (1)  ·  Loyola University (1)  ·  University of Arkansas (1)

Countries

United States (3)  ·  Germany (2)  ·  Egypt (1)

Top investigators

Wolfram H Jager, PhD (2)  ·  Alan J Wolffe, PhD (1)  ·  Allen C Sherman, PhD (1)  ·  Hany F Badawy, MD (1)  ·  Lynn James (1)

Results publications

PMID 24371246, PMID 25006228, PMID 26423260